Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
4/30/2013 10:21:06 AM
More...
|
Pfenex Inc. and Agila Biotech Private Limited Announce Joint Venture to Develop Biosimilar Products for the Global Market
4/16/2013 9:39:39 AM
More...
|
Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Capacity Expansion for cGMP CRM197 Production
1/16/2013 9:10:16 AM
More...
|
Pfenex Inc. Welcomes Kristi Sarno as a Director of Business Development
12/5/2012 11:47:40 AM
More...
|
Pfenex Inc. Awards Althea Technologies, Inc. a Contract for cGMP Manufacturing of Circumsporozoite Protein From Plasmodium Falciparum, a Key Malaria Antigen
10/24/2012 10:30:21 AM
More...
|
Pfenex Inc. Awarded Contract by the National Institute of Allergy And Infectious Diseases (NIAID) (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA)-based Anthrax Vaccine
10/17/2012 10:39:54 AM
More...
|
Frost & Sullivan Lauds Pfenex Inc. for Developing a Protein Expression Platform that Delivers Unparalleled Success and Speed
6/5/2012 12:19:47 PM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option With Pfenex Inc. to Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
5/1/2012 11:27:05 AM
More...
|
Pfenex Inc. and DNA 2.0, Inc. Collaborate on Protein Expression Technology
3/1/2012 11:38:30 AM
More...
|
Pfenex Inc. and ProZyme, Inc. Establish Joint Collaboration and Supply Agreement
1/10/2012 11:04:18 AM
More...
|
|